Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2014 Filed Feb 26, 2014 19:26 UTC |
KELLOGG PETER NExe V-P & CFO
|
GrantCommon Stock | 18,662 | $56.18 | $1,048,431.16 |
DisclosureSEC source: 0001225208-14-006295 · doc4.xml · nonDerivative · entry 1 KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,553.902 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 03/31/2011. Performance shares were paid out at 86 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 24, 2014 Filed Feb 26, 2014 19:51 UTC |
Canan JohnSr.V-P Finc-Global Controller
|
GrantCommon Stock | 2,913 | $56.18 | $163,652.34 |
DisclosureSEC source: 0001225208-14-006330 · doc4.xml · nonDerivative · entry 1 Canan John · CIK 0001374366 · Sr.V-P Finc-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,609.576 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 03/31/2011. Performance shares were paid out at 86 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 24, 2014 Filed Feb 26, 2014 19:51 UTC |
Golestani ClarkEVP & Chief Info Officer
|
GrantCommon Stock | 1,181 | $56.18 | $66,348.58 |
DisclosureSEC source: 0001225208-14-006331 · doc4.xml · nonDerivative · entry 1 Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,227.12 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 03/31/2011. Performance shares were paid out at 86 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 24, 2014 Filed Feb 26, 2014 19:51 UTC |
Heller Bridgette PExe.VP & Pres.Con.Hlth.Care
|
GrantCommon Stock | 5,213 | $56.18 | $292,866.34 |
DisclosureSEC source: 0001225208-14-006332 · doc4.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Exe.VP & Pres.Con.Hlth.Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,799.704 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 03/31/2011. Performance shares were paid out at 86 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 24, 2014 Filed Feb 26, 2014 19:51 UTC |
Rosenblatt MichaelExec V-P & Chief Med Officer
|
GrantCommon Stock | 4,907 | $56.18 | $275,675.26 |
DisclosureSEC source: 0001225208-14-006333 · doc4.xml · nonDerivative · entry 1 Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,438.832 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 03/31/2011. Performance shares were paid out at 86 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 24, 2014 Filed Feb 26, 2014 20:25 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
GrantCommon Stock | 2,414 | $56.18 | $135,618.52 |
DisclosureSEC source: 0001225208-14-006350 · doc4.xml · nonDerivative · entry 1 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,593.536 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 03/31/2011. Performance shares were paid out at 86 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 14, 2014 Filed Feb 14, 2014 22:11 UTC |
Golestani ClarkEVP & Chief Info Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,375 | $0.00 Strike: $48.24 | $0.00 |
DisclosureSEC source: 0001225208-14-004670 · doc4.xml · derivative · entry 6 Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,375 shares Expires 2014-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2014 Filed Feb 14, 2014 22:11 UTC |
Golestani ClarkEVP & Chief Info Officer
|
SaleCommon Stock | 4,800 | $55.47 | $266,267.04 |
DisclosureSEC source: 0001225208-14-004670 · doc4.xml · nonDerivative · entry 3 Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,046.12 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 14, 2014 Filed Feb 14, 2014 22:11 UTC |
Golestani ClarkEVP & Chief Info Officer
|
SaleCommon Stock | 1,190 | $55.47 | $66,009.30 |
DisclosureSEC source: 0001225208-14-004670 · doc4.xml · nonDerivative · entry 2 Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,846.12 Read SEC document |
| February 14, 2014 Filed Feb 14, 2014 22:11 UTC |
Golestani ClarkEVP & Chief Info Officer
|
Exercise / conversionCommon Stock | 6,375 | $48.24 | $307,530.00 |
DisclosureSEC source: 0001225208-14-004670 · doc4.xml · nonDerivative · entry 1 Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,036.12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2014 Filed Feb 14, 2014 16:17 UTC |
Heller Bridgette PExe.VP & Pres.Con.Hlth.Care
|
Exercise / conversionStock Option (right to buy) · Derivative | 49,750 | $0.00 Strike: $36.56 | $0.00 |
DisclosureSEC source: 0001225208-14-004603 · doc4.xml · derivative · entry 3 Heller Bridgette P · CIK 0001485616 · Exe.VP & Pres.Con.Hlth.Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,877 Underlying: Common Stock · 49,750 shares Expires 2021-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2014 Filed Feb 14, 2014 16:17 UTC |
Heller Bridgette PExe.VP & Pres.Con.Hlth.Care
|
SaleCommon Stock | 43,870 | $55.04 | $2,414,569.70 |
DisclosureSEC source: 0001225208-14-004603 · doc4.xml · nonDerivative · entry 2 Heller Bridgette P · CIK 0001485616 · Exe.VP & Pres.Con.Hlth.Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,586.704 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.01 to $55.09, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 13, 2014 Filed Feb 14, 2014 16:17 UTC |
Heller Bridgette PExe.VP & Pres.Con.Hlth.Care
|
Exercise / conversionCommon Stock | 49,750 | $36.56 | $1,818,860.00 |
DisclosureSEC source: 0001225208-14-004603 · doc4.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Exe.VP & Pres.Con.Hlth.Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,456.704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2014 Filed Feb 11, 2014 22:07 UTC |
Canan JohnSr.V-P Finc-Global Controller
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $48.24 | $0.00 |
DisclosureSEC source: 0001225208-14-004114 · doc4.xml · derivative · entry 4 Canan John · CIK 0001374366 · Sr.V-P Finc-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2014-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2014 Filed Feb 11, 2014 22:07 UTC |
Canan JohnSr.V-P Finc-Global Controller
|
SaleCommon Stock | 10,000 | $55.70 | $557,002.00 |
DisclosureSEC source: 0001225208-14-004114 · doc4.xml · nonDerivative · entry 2 Canan John · CIK 0001374366 · Sr.V-P Finc-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,696.576 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.68 to $55.72, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 11, 2014 Filed Feb 11, 2014 22:07 UTC |
Canan JohnSr.V-P Finc-Global Controller
|
Exercise / conversionCommon Stock | 10,000 | $48.24 | $482,400.00 |
DisclosureSEC source: 0001225208-14-004114 · doc4.xml · nonDerivative · entry 1 Canan John · CIK 0001374366 · Sr.V-P Finc-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,696.576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2014 Filed Feb 11, 2014 22:34 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $48.24 | $0.00 |
DisclosureSEC source: 0001225208-14-004138 · doc4.xml · derivative · entry 4 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires 2014-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2014 Filed Feb 11, 2014 22:34 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
SaleCommon Stock | 41,520 | $54.52 | $2,263,682.86 |
DisclosureSEC source: 0001225208-14-004138 · doc4.xml · nonDerivative · entry 2 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,829.063 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.47 to $54.60, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 11, 2014 Filed Feb 11, 2014 22:34 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 45,000 | $48.24 | $2,170,800.00 |
DisclosureSEC source: 0001225208-14-004138 · doc4.xml · nonDerivative · entry 1 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,349.063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2014 Filed Feb 13, 2014 15:12 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $45.41 | $0.00 |
DisclosureSEC source: 0001225208-14-004449 · doc4.xml · derivative · entry 9 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2014-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2014 Filed Feb 13, 2014 15:12 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $47.39 | $0.00 |
DisclosureSEC source: 0001225208-14-004449 · doc4.xml · derivative · entry 8 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2014-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2014 Filed Feb 13, 2014 15:12 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $48.24 | $0.00 |
DisclosureSEC source: 0001225208-14-004449 · doc4.xml · derivative · entry 7 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2014-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2014 Filed Feb 13, 2014 15:12 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
OtherCommon Stock - 401(k) Plan | 4,040.3746 | $55.70 | $225,048.87 |
DisclosureSEC source: 0001225208-14-004449 · doc4.xml · nonDerivative · entry 5 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Disclosed balance after: 0 F2 · shares: Includes 97.2259 shares acquired under the Merck U.S. Savings Plan, a 401(k) plan, since the date of the reporting person's last ownership report. Read SEC document |
| February 11, 2014 Filed Feb 13, 2014 15:12 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
SaleCommon Stock | 18,000 | $55.61 | $1,000,935.00 |
DisclosureSEC source: 0001225208-14-004449 · doc4.xml · nonDerivative · entry 4 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.52 to $55.72, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Read SEC document |
| February 11, 2014 Filed Feb 13, 2014 15:12 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Exercise / conversionCommon Stock | 2,500 | $47.39 | $118,475.00 |
DisclosureSEC source: 0001225208-14-004449 · doc4.xml · nonDerivative · entry 3 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2014 Filed Feb 13, 2014 15:12 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Exercise / conversionCommon Stock | 3,000 | $45.41 | $136,230.00 |
DisclosureSEC source: 0001225208-14-004449 · doc4.xml · nonDerivative · entry 2 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2014 Filed Feb 13, 2014 15:12 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Exercise / conversionCommon Stock | 12,500 | $48.24 | $603,000.00 |
DisclosureSEC source: 0001225208-14-004449 · doc4.xml · nonDerivative · entry 1 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2014 Filed Feb 11, 2014 20:41 UTC |
WEEKS WENDELL PDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $47.23 | $0.00 |
DisclosureSEC source: 0001225208-14-004041 · doc4.xml · derivative · entry 4 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2014-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2014 Filed Feb 11, 2014 20:41 UTC |
WEEKS WENDELL PDirector
|
SaleCommon Stock | 5,000 | $54.26 | $271,282.50 |
DisclosureSEC source: 0001225208-14-004041 · doc4.xml · nonDerivative · entry 2 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.24 to $54.37, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Read SEC document |
| February 10, 2014 Filed Feb 11, 2014 20:41 UTC |
WEEKS WENDELL PDirector
|
Exercise / conversionCommon Stock | 5,000 | $47.23 | $236,150.00 |
DisclosureSEC source: 0001225208-14-004041 · doc4.xml · nonDerivative · entry 1 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2014 Filed Feb 11, 2014 20:48 UTC |
Wendell Peter CDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $47.23 | $0.00 |
DisclosureSEC source: 0001225208-14-004043 · doc4.xml · derivative · entry 3 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2014-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2014 Filed Feb 11, 2014 20:48 UTC |
Wendell Peter CDirector
|
SaleCommon Stock | 5,000 | $54.44 | $272,193.00 |
DisclosureSEC source: 0001225208-14-004043 · doc4.xml · nonDerivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.43 to $54.47, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Read SEC document |
| February 10, 2014 Filed Feb 11, 2014 20:48 UTC |
Wendell Peter CDirector
|
Exercise / conversionCommon Stock | 5,000 | $47.23 | $236,150.00 |
DisclosureSEC source: 0001225208-14-004043 · doc4.xml · nonDerivative · entry 1 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2014 Filed Feb 11, 2014 20:54 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $48.24 | $0.00 |
DisclosureSEC source: 0001225208-14-004045 · doc4.xml · derivative · entry 4 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2014-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2014 Filed Feb 11, 2014 20:54 UTC |
Deese Willie AExe V-P & Pres. MMD
|
SaleCommon Stock | 50,000 | $54.68 | $2,734,155.00 |
DisclosureSEC source: 0001225208-14-004045 · doc4.xml · nonDerivative · entry 2 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,048.9678 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.61 to $54.78, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 10, 2014 Filed Feb 11, 2014 20:54 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Exercise / conversionCommon Stock | 20,000 | $48.24 | $964,800.00 |
DisclosureSEC source: 0001225208-14-004045 · doc4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,048.9678 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2014 Filed Jan 28, 2014 15:09 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Exercise / conversionStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $47.79 | $0.00 |
DisclosureSEC source: 0001225208-14-002448 · doc4.xml · derivative · entry 3 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2014-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2014 Filed Jan 28, 2014 15:09 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Exercise / conversionCommon Stock | 30,000 | $47.79 | $1,433,700.00 |
DisclosureSEC source: 0001225208-14-002448 · doc4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,048.9678 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2013 Filed Jan 2, 2014 21:46 UTC |
HARRISON WILLIAM B JRDirector
|
GrantPhantom Stock · Derivative | 724.2757 | $50.05 | $36,250.00 |
DisclosureSEC source: 0001225208-14-000152 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,612.3277 Underlying: Common Stock · 724.2757 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2013 Filed Jan 2, 2014 21:49 UTC |
LAZARUS ROCHELLE BDirector
|
GrantPhantom Stock · Derivative | 499.5005 | $50.05 | $25,000.00 |
DisclosureSEC source: 0001225208-14-000154 · doc4.xml · derivative · entry 3 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,927.7915 Underlying: Common Stock · 499.5005 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2013 Filed Jan 2, 2014 21:50 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 549.4505 | $50.05 | $27,500.00 |
DisclosureSEC source: 0001225208-14-000156 · doc4.xml · derivative · entry 3 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,553.9845 Underlying: Common Stock · 549.4505 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2013 Filed Jan 2, 2014 21:53 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 499.5005 | $50.05 | $25,000.00 |
DisclosureSEC source: 0001225208-14-000157 · doc4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,860.3275 Underlying: Common Stock · 499.5005 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 16, 2013 Filed Dec 18, 2013 15:18 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
GiftCommon Stock | 1,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-025639 · doc4.xml · nonDerivative · entry 1 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,239.263 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| November 13, 2013 Filed Nov 14, 2013 16:03 UTC |
KELLOGG PETER NExe V-P & CFO
|
Exercise / conversionRestricted Stock Unit · Derivative | 40,000 | $47.59 | $1,903,600.00 |
DisclosureSEC source: 0001225208-13-023472 · doc4.xml · derivative · entry 3 KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2013-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F3 · derivative.exercise_date: 40,000 Restricted Stock Units vested on November 13, 2010 (reduced by 18,540 withheld for taxes) and 40,000 vested on November 13, 2013 (reduced by 20,740 withheld for taxes). Read SEC document |
| November 13, 2013 Filed Nov 14, 2013 16:03 UTC |
KELLOGG PETER NExe V-P & CFO
|
Tax withholdingCommon Stock | 20,740 | $47.59 | $987,016.60 |
DisclosureSEC source: 0001225208-13-023472 · doc4.xml · nonDerivative · entry 2 KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,891.902 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| November 13, 2013 Filed Nov 14, 2013 16:03 UTC |
KELLOGG PETER NExe V-P & CFO
|
Exercise / conversionCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-023472 · doc4.xml · nonDerivative · entry 1 KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,631.902 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2013 Filed Nov 4, 2013 21:33 UTC |
REPRESAS CARLOS EDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,334 | $0.00 Strike: $24.30 | $0.00 |
DisclosureSEC source: 0001225208-13-022799 · doc4.xml · derivative · entry 3 REPRESAS CARLOS E · CIK 0001216083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,334 shares Expires 2019-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vests in three equal annual installments beginning May 1, 2010. Read SEC document |
| November 04, 2013 Filed Nov 4, 2013 21:33 UTC |
REPRESAS CARLOS EDirector
|
Exercise / conversionCommon Stock | 3,334 | $24.30 | $81,016.20 |
DisclosureSEC source: 0001225208-13-022799 · doc4.xml · nonDerivative · entry 1 REPRESAS CARLOS E · CIK 0001216083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,834 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2013 Filed Nov 1, 2013 14:10 UTC |
Cech Thomas RDirector
|
SaleCommon Stock | 500 | $45.13 | $22,565.00 |
DisclosureSEC source: 0001225208-13-022571 · doc4.xml · nonDerivative · entry 1 Cech Thomas R · CIK 0001464680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 Read SEC document |
| September 30, 2013 Filed Oct 2, 2013 13:50 UTC |
HARRISON WILLIAM B JRDirector
|
GrantPhantom Stock · Derivative | 761.3947 | $47.61 | $36,250.00 |
DisclosureSEC source: 0001225208-13-020961 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,352.9681 Underlying: Common Stock · 761.3947 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.